07 Jan 2001

Coliriocilina prednisona - España

Updated: 07 Jan 2001

Coliriocilina prednisona colirio 5 ml

Procesos inflamatorios e infecciones oculares: Uveitis, conjuntivitis, iritis, iridociclitis, escleroqueratitis, quemaduras, trauma químico, neuritis óptica.

Coliriocilina prednisona Description, Presentation and Dosage

Coliriocilina prednisona Description

Coliriocilina prednisona Drug Class Description

Corticoides oftalmologicos con neomicina

Coliriocilina prednisona Drug Description

COLIRIO

Coliriocilina prednisona Presentation

Coliriocilina prednisona Presentation

Adultos y niños: Instilar una o dos gotas en el ojo enfermo dos o cuatro veces al día. Excepcionalmente, pueden administrarse 1-2 gotas cada dos horas.

Coliriocilina prednisona Manufacturer

MEDICAL

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Coliriocilina prednisona Dosage

Coliriocilina prednisona Adult Dosage

Sustancia susceptible de producir un resultado positivo en un control de dopaje. Sólo se acepta su uso en el deporte de competición en las circunstancias que recoge el Anexo de la Resolución 21/3/2000 del Consejo Superior de Deportes.

Coliriocilina prednisona Precautions, Reactions and Contraindications

Coliriocilina prednisona Special Precautions

Coliriocilina prednisona Special Precautions

Hipersensibilidad a otros antibióticos aminoglucosídicos.

Coliriocilina prednisona Adverse Reactions

Coliriocilina prednisona Adverse Reactions

Ocasionalmente, reacciones de hipersensibilidad (picor, sensación de quemazón, enrojecimiento, lacrimación, erupciones), sobreinfecciones por microorganismos no susceptibles. En tratamientos prolongados: cataratas, aumento de la presión intraocular.

Coliriocilina prednisona Contraindications

Coliriocilina prednisona Contraindications

Hipersensibilidad al medicamento. Glaucoma. Enfermedades fúngicas oculares. Enfermedades víricas de la córnea y conjuntiva, queratitis herpética, varicela, tuberculosis ocular.

Related Drugs -

Back to top